Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Free Radic Res. 2010 Oct 18;45(2):165–176. doi: 10.3109/10715762.2010.521154

Figure 2. Sputum MPO levels in CF patients.

Figure 2

CF patients had varied levels of sputum MPO levels and were categorized into low, moderate and high groups comprising 27%, 33% and 39% of total patients. Values are presented as mean ± SEM.